Since the hyperactivation of Akt and ERK is already present in most bladder cancers 20, 25, the phosphorylation of Akt and ERK by hyperoside might not significantly enhance their activity further, which could explain why they do not dominate the story of hyperoside. This evidence concerns the gene AKT1 and urinary bladder carcinoma.